Somatic hypermutation of immunoglobulin and non-immunoglobulin genes.

AUTOR(ES)

Storb, U

RESUMO

Somatic hypermutation (SHM) of immunoglobulin (Ig) genes is a highly specific mechanism restricted to B lymphocytes during only a few cell generations. Data presented here suggest that transcription of the target genes is required, but not sufficient for SHM. Presumably, cis-acting elements, such as those present in the Ig enhancers, are required to target a mutator factor (MuF) to Ig and human BCL-6 genes. It is postulated that the MuF travels with the transcribing RNA polymerase and is deposited on the target gene when the polymerase pauses. Point mutations, and rare deletions and insertions, are created by the combined actions of MuF and certain DNA polymerases. A subset of the mutations is corrected during SHM by DNA mismatch repair.

Documentos Relacionados

• Improved rubella hemagglutination inhibtion test: inactivation of non-immunoglobulin hemagglutination inhibitors by phospholipase C.
• Non-immunoglobulin fraction of human milk protects rabbits against enterotoxin-induced intestinal fluid secretion.
• Virus-specific neutralization by a soluble non-immunoglobulin factor found naturally in normal mouse sera.
• Evolution and the molecular basis of somatic hypermutation of antigen receptor genes.
• Identification of non-immunoglobulin A-Fc-binding forms and low-molecular-weight secreted forms of the group B streptococcal beta antigen.